Back to Search
REBECCA SCHAUB, MD
MD
Pediatric Endocrinology Physician
NPI: 1609042209Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
N8846(TX)
Pediatric Endocrinology PhysicianPrimary
Pediatrics — Pediatric Endocrinology
Code: 2080P0205X
N8846(TX)38778(OK)
Research & Publications (20)
Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779.
PMID 19422452·J Thromb Haemost·2009
7-preclinical
Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia.
PMID 19464736·Psychiatry Res·2009
4-observational
Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins.
PMID 19364981·Circulation·2009
7-preclinical
Observation of all the intermediate steps of a chemical reaction on an oxide surface by scanning tunneling microscopy.
PMID 19309169·ACS Nano·2009
8-other
Narrowing critical regions and determining penetrance for selected 18q- phenotypes.
PMID 19533771·Am J Med Genet A·2009
8-other
The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
PMID 19637097·Platelets·2009
8-other
[Discussing and evaluating professional behaviour. 1. Academic Centre for Oral Health Groningen].
PMID 18979964·Ned Tijdschr Tandheelkd·2008
8-other
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.
PMID 18024786·J Pharmacol Exp Ther·2008
4-observational
Aptamers as candidate therapeutics for cardiovascular indications.
PMID 18222730·Curr Opin Pharmacol·2008
6-review
Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.
PMID 18278184·Thromb Haemost·2008
4-observational
Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.
PMID 18392333·Thromb Haemost·2008
7-preclinical
The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
PMID 17721623·Thromb Haemost·2007
7-preclinical
Proteomic identification of endothelial proteins isolated in situ from atherosclerotic aorta via systemic perfusion.
PMID 17997517·J Proteome Res·2007
4-observational
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
PMID 17616301·J Am Coll Cardiol·2007
8-other
2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists.
PMID 17201409·J Med Chem·2007
7-preclinical
Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.
PMID 17334507·Thromb Haemost·2007
4-observational
First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers.
PMID 18025536·Circulation·2007
2-rct
Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
PMID 17175381·Cancer Genet Cytogenet·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 CHILDRENS AVE STE 4D
OKLAHOMA CITY, OK 73104 - Phone
- (405) 271-8001
Quick Facts
- NPI
- 1609042209
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile